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The natural course of Chlamydia trachomatis urogenital tract infections varies
between individuals. While protective immunity can occur, some women can become
reinfected, contributing to the development of severe pathology. While the reasons
for these differences are unknown, an individual’s response to induced interferon-γ
(IFN-γ) is suggested to be critical. IFN-γ induction of the enzyme indoleamine
2,3-dioxygenase, which depletes tryptophan, may be the key. One hypothesis suggests
that indole-producing bacteria in the vaginal microbiota can provide a substrate for the
Chlamydia to synthesize tryptophan, rescuing the Chlamydia from host IFN-γ attack.
We studied a cohort of 25 women who were either, Chlamydia negative, Chlamydia
positive with a single infection, or Chlamydia positive with repeated infection, to test
our hypothesis. We characterized their vaginal microbiota, cytokine response, as well
as their tryptophan, kynurenine and indole concentrations directly in vaginal secretions.
We found that C. trachomatis urogenital tract infections either initial or repeat infections,
were associated with elevated vaginal kynurenine/tryptophan ratios, primarily as a result
of elevated kynurenine levels. In addition, vaginal microbiota of community state type
(CST) IV showed significantly lower vaginal tryptophan levels compared to CST I and
III, which might be related to a higher abundance of indole producers found within this
group. Furthermore, we found a higher abundance of indole producers in women who
cleared their Chlamydia infection post antibiotic treatment. This study demonstrates for
the first time in vivo, the association between high vaginal kynurenine/tryptophan ratios
and C. trachomatis infections. In addition, tryptophan depletion was associated with
vaginal microbiota of CST IV.
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INTRODUCTION
Genital infections with Chlamydia trachomatis continue to
be highly prevalent despite sensitive diagnosis and effective
antibiotic treatments being available (Lanjouw et al., 2015;
Newman et al., 2015). Despite all efforts, the natural course
of C.trachomatis infections are still not fully understood nor is
the precise immune profile of protection. While some women
apparently do develop some level of protective immunity
(Brunham et al., 1996; Cohen et al., 2005; Batteiger et al., 2010),
others are susceptible to repeated infections that can result in
severe pathology. One of the most important immune responses
for the development of protective immunity against Chlamydia
infection is characterized by antigen-specific interferon-gamma
(IFN-γ) secretion by CD4+ T cells (Cohen et al., 2000, 2005;
Barral et al., 2014; Hafner et al., 2014). IFN-γ is considered
to be an anti-chlamydial agent due to its ability to upregulate
the enzyme indoleamine 2,3-dioxygenase (IDO1) (Byrne et al.,
1986). IDO1 catabolizes the amino acid tryptophan into
N-formylkynurenine (Takao et al., 1978), depleting the host
cell tryptophan pools. Chlamydia is a tryptophan auxotroph
and depends on the host pools of tryptophan to establish
and maintain its infection (Mcclarty, 1994; Xie et al., 2002).
However, unlike other Chlamydia sub-species (such as ocular
trachoma strains), genital C. trachomatis strains are able
to use exogenous indole which they can convert back to
tryptophan using their functional tryptophan synthase gene
(trpBA) (Caldwell et al., 2003). One hypothesis suggests that
indole-producing bacteria in the vaginal microbiota might play
a role in C. trachomatis infections by providing exogenous
indole, allowing the Chlamydia to overcome the host IFN-γ-
mediated immune response (Morrison, 2003). Indole producing
bacteria may be prevalent in the female genital tract of some
women, most likely with more diverse anaerobic vaginal bacterial
communities and hence, this could be a direct source of indole
/ tryptophan for the Chlamydia (Ziklo et al., 2016a). Indole is
an important signaling molecule produced by many bacterial
species colonizing some of the mucosal sites in the human body,
in particular the gastrointestinal tract (Lee and Lee, 2010). In
addition, indole was previously detected in genital secretions of
two women who were infected with Chlamydia (Lewis et al.,
2014).
IDO1 can be produced by many cell types in response
to specific cytokines such as IFN-γ, IL-1β, TNF-α, and IL6
(Shirey et al., 2006; Campbell et al., 2014). IDO1 production has
been associated with reduced differentiation of IL-17 producing
CD4+ T cells (Favre et al., 2010), increased production of
anti-inflammatory IL-10 (De Luca et al., 2013), tolerance
and immunosuppression (Moffett and Namboodiri, 2003).
Catabolism of tryptophan through the kynurenine pathway has
also been shown to be involved in many diseases and disorders
(Campbell et al., 2014; Heng et al., 2016), while kynurenine
specifically has been shown to be a very important biomarker
for disease progression (Chen and Guillemin, 2009), and has
been associated with dysbiosis of the gut microbiota (Vujkovic-
Cvijin et al., 2014). However, as an immune-suppressor, IDO1 has
been found to have beneficial effects in tolerance and one study
reported that high kynurenine was associated with a healthy
state of the vaginal microbiome in comparison to women with
bacterial vaginosis (BV) (Vitali et al., 2015).
We know that the vaginal tract microbiota has an important
role in health and disease andmight have severe consequences for
reproductive outcomes (White et al., 2011; Moreno et al., 2016),
as well as reproductive disorders, such as pelvic inflammatory
disease, endometriosis, ectopic pregnancy, preterm birth and
tubal factor infertility (McGregor, 2000; Oakeshott et al., 2002;
Ness et al., 2005; Durugbo et al., 2015). BV is a state in which
the vaginal microbiome shifts from being dominated by key
Lactobacillus spp. to one with a higher proportion of non-
lactobacilli communities. BV is also characterized by higher
vaginal pH levels, fishy odor and discharge and has been shown to
be highly associated with sexually transmitted infections such as
C. trachomatis, as well as reproductive complications (Wiesenfeld
et al., 2003; Brotman et al., 2010; White et al., 2011). Community
state types (CST) are used to characterize vaginal microbiota
based on the dominant Lactobacillus species (CST I, II, III, and
IV) (Ravel et al., 2011). However, CST IV is characterized by a
higher abundance of anaerobic non-Lactobacillus bacteria, such
as Prevotella, Atopobium, Gardnerella, Parvimonas,Megasphaera,
Peptoniphilus, and Streptococcus, and is often associated with
higher pH and higher Nugent score (Ravel et al., 2011; Huang
et al., 2014; Albert et al., 2015). The relationship between the
vaginal microbiota and its host are orchestrated by important
biochemical compounds, among them are tryptophan and
kynurenine produced either by the host’s catabolic pathways, the
microbiome or mycobiome colonizing the area and often have
an effect on the host immune response (De Luca et al., 2013;
Mirmonsef et al., 2014; Romani et al., 2014; Nelson et al., 2015).
This study aimed to answer the question evolving around
a decade-old hypothesis, in regards to the indole-producing
bacterial proportion within the genital microbiome that
potentially contributes to C. trachomatis immune evasion
through tryptophan starvation. We have previously found
that indole-producing bacterial supernatant was able to rescue
C. trachomatis after tryptophan depletion in vitro (Ziklo et al.,
2016b). We have expanded this in vitro data to analyze a small
cohort of women attending a Sexual Health Clinic, either
Chlamydia negative, Chlamydia positive or Chlamydia repeat-
positive. We measured the women’s microbiome, cytokine
production, along with vaginal tryptophan, kynurenine and
indole levels. In this study, we provide evidence that women
with repeated C. trachomatis genital infection have significantly
higher kynurenine and kynurenine/tryptophan ratio levels,




We have collected 37 samples from 25 women, who attended
the Sexual Health Clinic in Nambour, Australia, at different time
points (Supplementary Table 1). Women were diagnosed for
Chlamydia infection by the clinic using Cobas R© 4800 CT/NG
Test (Roshe, Australia) (Rockett et al., 2010), and were either
Chlamydia trachomatis negative (CT-N; n = 10), Chlamydia
positive with first infection (CT-P; n = 11) or Chlamydia
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positive with repeated infection in the past year (CT-RP; n = 3).
Women with first current Chlamydia infection were treated
with azithromycin 500mg and were invited to second and
third visits for follow up [post antibiotic treatment (PAT); n
= 13]. Two high vaginal swab samples, one cervical secretion
sample and a 5ml blood sample were collected from each
woman. Women’s samples were diagnosed for the presence
of clue cells using Gram stain along with vaginal pH and
Nugent score. This study was carried out in accordance with the
recommendations of University of the Sunshine Coast, Human
Ethics Committee (number A/14/623), and Prince Charles
Hospital Human Research Ethics (number HREC/14/QPCH/14),
with written informed consent from all subjects. All subjects gave
written informed consent in accordance with the Declaration of
Helsinki. The protocol was approved by the University of the
Sunshine Coast, Human Ethics Committee and Prince Charles
Hospital Human Research Ethics.
Elution of Vaginal Secretions
LASIK PVA eye sponges (Visitec, USA) were placed in the
posterior fornix of the vagina for 2min to absorb secretions.
Sponges were immediately placed at −20◦C until vaginal fluids
were eluted at the same day, as previously described by Kozlowski
et al. (2000), using 300µl of PBS containing 1%Bacterial Protease
Inhibitor (Sigma, Australia) and 10% igepal (Sigma, Australia).
Tryptophan and Kynurenine ELISA
Tryptophan and kynurenine concentrations in vaginal
secretions samples were determined using tryptophan and
kynurenine ELISA assay (Immusmol, France), according to the
manufacturer’s instructions. Briefly, 20 µl of cervical secretion
was used from each sample in a 96-well plate competitive
ELISA assay. Measurements of O.D. were converted into
concentrations according to a standard curve. Measurements
were corrected according to each of the samples’ dilution factor.
Kynurenine/tryptophan ratio was calculated by dividing the
measurements from the two kits.
Measurement of Cytokines in Vaginal
Secretions
Three cytokines, IFN-γ, IL-17, and IL-10 were measured from
women’s cervical secretions, using ELISA assay (Elisakit.com,
VIC, Australia), according to the manufacturer’s instructions.
Protein levels in pg/ml were determined according to a standard
curve and measurements were corrected according to each of the
samples’ dilution factor.
Analysis of the Vaginal Microbiome
High vaginal swab samples were stored in 1ml of RNAlater
at −80◦C until processed. DNA was extracted from the swabs
using QIAamp Mini Kit (Qiagen, Australia) according to the
manufacturer’s instructions with minor changes. Briefly, swab
tips stored in RNAlater were vortexed for 3min, then 0.5ml
were transferred into a new 1.5ml sterile Eppendorf tube and
centrifuged for 30min at 16,000 × g. Supernatant was discarded
and pellet was resuspended in 50 µl of sterile Tris-EDTA
buffer (TE, pH 8). Samples were heated to 95◦C for 10min,
cooled, then 130 µl of ATL buffer and 20 µl of proteinase K
were added. Samples were then incubated overnight at 56◦C.
Following incubation, extraction method was performed per
manufacturer’s kit instructions. DNA concentrations and purity
were determined using Qubit (Thermo-Fisher, Australia). PCR
amplification of the V3-V4 hypervariable regions of the 16S
rRNA gene was performed using dual-indexed primers (Fadrosh
et al., 2014). PCR amplicons of the samples and controls were
created using barcoded 319F and 806R primers at a concentration
of 1µM with HiFi Hot Start Ready Mix (KAPA Biosystems,
Cape Town, South Africa). The reaction was performed on a
NexusMastercycler (Eppendorf, Hamburg, Germany) with 3min
of initial denaturation at 95◦C, followed by 30 cycles at 95◦C for
15 s, 55◦C for 15 s, and 72◦C for 30 s and a final extension step
at 72◦C for 5min. PCR products were cleaned and standardized
using SequalPrepTM Normalization Kit (Invitrogen, Carlsbad,
CA) and then pooled. Library was then concentrated using
DNA Clean and Concentrator-25 (Zymo Research, Irvine, CA),
and primers removed using a Gel DNA Recovery Kit (Zymo
Research; Irvine, CA). The libraries were sequenced on theMiSeq
platform using 600-cycle kit chemistry v3 (Illumina, San Diego,
CA). The raw MiSeq data files were pre-processed using the
method previously described (Fadrosh et al., 2014), with PEAR
for merging the paired end reads (Zhang et al., 2014), CutAdapt
for trimming barcode/primer (Martin, 2011), and vsearch for
detection and removal of chimeric sequences (Rognes et al.,
2014). Pre-processed sequence data were then analyzed using
QIIME (v1.9) (Caporaso et al., 2012). Operational taxonomic
units (OTUs) were picked using a closed-reference strategy
(Rideout et al., 2014) using a previously published vaginal specific
16S database (Srinivasan et al., 2012), which was modified to
contain additional indole producing bacteria known to be present
in the vaginal microbiome (Ziklo et al., 2016a).
Statistical Analysis
Data analysis was performed in Graph Pad Prism V. 7.01 (Graph
Pad Software, Australia) and presented as mean ± standard
deviation (SD). Statistical differences were analyzed using Mann-
Whitney test. Correlation analysis was performed using Pearson
test. Comparative analysis of specific bacteria in the vaginal
microbiome data was performed using Kruskal Wallis test in
QIIME (Caporaso et al., 2012). Contingency tables were analyzed
using Fisher’s exact test.
RESULTS
Higher Kynurenine/Tryptophan Ratio
Levels Are Present in Chlamydia Positive
(Single or Repeat Infections) Compared to
Chlamydia Negative Women
IFN-γ is known to be a key regulator of chlamydial growth
and one of the mechanisms is via IDO1 upregulation and
depletion of tryptophan, by conversion into kynurenine
(Figure 1). To determine if vaginal tract levels of available
tryptophan or its product, kynurenine, might correlate with
an individual’s response to initial or repeat infections with
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 January 2018 | Volume 8 | Article 1
Ziklo et al. Interferon-Gamma Response to Chlamydia trachomatis Infections
FIGURE 1 | IFN-γ-tryptophan-kynurenine and indole pathways. IFN-γ induces IDO1 levels, which catabolizes tryptophan through the kynurenine pathway. Tryptophan
depletion and high levels of kynurenine down-regulates IFN-γ activity. Chlamydial tryptophan synthase gene (trpBA) converts available indole back to tryptophan, as
well as other vaginal tract bacterial trpBA. Indole-producing bacteria can synthesis indole from tryptophan using tnaA gene. Tryptophan can be accumulated in the
epithelial cell in many ways, such as through diet, cell degradation and microbial source.
C. trachomatis, we measured protein levels of tryptophan
and kynurenine from vaginal secretion. While we did not
find a significant correlation with tryptophan levels alone
(Figure 2C), we did find that Chlamydia positive women, with
either single or repeated infection, had significantly higher
kynurenine/tryptophan ratios (p < 0.005) when compared to
Chlamydia negative women (Figure 2A). In addition, women
with repeated Chlamydia infections had significantly higher
kynurenine levels in comparison to Chlamydia negative women
(p < 0.05, Figure 2B).
Women with Repeated Chlamydial
Infections Have Reduced Levels of IFN-γ
and IL-17
Higher kynurenine/tryptophan ratio levels in women with
an active Chlamydia infection supports the hypothesis of an
anti-chlamydial IFN-γ immune response to the pathogen,
subsequently, activating the enzyme IDO1 to deplete tryptophan
into kynurenine. However, when looking at the vaginal secretion
IFN-γ response of the women in our cohort, although not
significantly different, we did find that women with repeated
chlamydial infections (CT-RP) actually had reduced levels
of IFN-γ, as well as IL-17 (Figures 2D,E), in comparison
with Chlamydia negative women. In addition, we found that
women with a single chlamydial infection (CT-P) had slightly
higher vaginal IL-10 levels, although not significantly different
(Figure 2F).
Women with CST IV Have the Lowest
Vaginal Tryptophan Levels
The metabolic pathway involving IFN-γ-induced tryptophan
depletion into kynurenine is regulated bymany factors thatmight
induce or inhibit IDO1 activity. One key source of regulation
might be the vaginal microbiome, with healthy women having
a microbiome dominated by lactobacilli and in comparison,
women with dysbiosis (such as CST IV dominant and BV) having
fewer lactobacilli and more anaerobic bacteria. We determined
the vaginal 16SrRNA microbiota profiles for all women in
our trial (Figure 3). In our cohort, 38% of the women had a
microbiome of CST I, 46% of the women had CST III and 16%
had CST IV (Figure 3B). Women with CST IV had a higher
Nugent score of 7-10 (Fisher’s exact test, p= 0.0007), pH≥ 5 (p<
0.0001) (Figure 3A) and higher presence of clue cells according
to Gram stain (p = 0.0197) (not shown). Women with CST IV
(16%) were less likely to be Chlamydia negative than those with
CSTI (36%) or CSTIII (24%) (Figures 3C–E). Although this is
not statistically significant (Fisher’s p= 0.367), this trend suggests
an association between previous or current chlamydial infections
and vaginal microbiota dysbiosis as characterized by CST IV.
Next, we wanted to investigate the association we found
between vaginal microbial community composition and the
biochemical factors associated with C. trachomatis infections.
Lactic acid is known to inactivate C. trachomatis (Gong et al.,
2014), therefore, the absence of Lactobacillus spp. in women
with CST IV might promote a suitable environment for the
Chlamydia. Apart from lactic acid, kynurenine and tryptophan
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FIGURE 2 | Vaginal kynurenine and tryptophan levels according to women’s chlamydial infection status and their association with vaginal cytokine response.
(A) Kynurenine/tryptophan ratio, (B) kynurenine (ng/ml), and (C) tryptophan (µg/ml) comparison between Chlamydia negative (CT-N; n = 10), Chlamydia positive
(CT-P; n = 11), post antibiotic treatment (PAT; n = 13) and repeated Chlamydia infections (CT-RP; n = 3). Cytokines (D) IFN-γ, (E) IL-17, and (F) IL-10 levels (pg/ml)
measured from women’s vaginal secretions samples according to their Chlamydia infection status. Significant differences are indicated in the figure, using
Mann-Whitney test, p < 0.05. Non-significant results are indicated in the figure (*ns). Data are presented as mean with SD.
levels are also expected to have an impact on chlamydial
infection. Despite the relatively low sample size, we found that
women with CST IV had significantly lower tryptophan levels
in comparison to women with CST I (p = 0.0058) and women
with CST III (p = 0.0126) (Figure 4A). On the other hand, this
time kynurenine levels were the same in women with CST I, III,
and IV (Figure 4B) suggesting that it is unlikely that tryptophan
depletion is due to host cell IDO1 activity (Figure 4C). Perhaps
this suggests that low tryptophan levels are due to metabolism
of some of the members in the bacterial community of CST
IV and are related to dysbiosis. In addition, when evaluating
the tryptophan and kynurenine levels according to Chlamydia
infection status in each CST, we found that for women who are
Chlamydia negative, CST is a strong predictor for tryptophan
levels. This was indicated by the observation that women with
CST I had higher tryptophan levels, followed by CST III and CST
IV with lowest levels (Supplementary Figure S1A). In addition,
CST IV and repeated Chlamydia infection are strong estimators
for high kynurenine levels as well as high kynurenine/tryptophan
ratios (Supplementary Figures S1B,C).
Regardless of CST Classification, Higher
Abundance of Streptococcus spp. and
Peptoniphilus spp. Were Found in Women
with Higher Kynurenine/Tryptophan Ratios
Because we could not find any differences in vaginal kynurenine
levels of women with CST I, III, and IV, we hypothesized
that the low tryptophan levels might be due to tryptophan
metabolism in some of the bacterial members of CST IV. We
conducted a comparative analysis with kynurenine, tryptophan
and kynurenine/tryptophan ratio levels using Kruskal-Wallis
test. Although we could not find a significant correlation with
the individual measurements of kynurenine and tryptophan (not
shown), we did find that a high kynurenine/tryptophan
ratio significantly correlated with higher abundance of
Streptococcus spp. (p = 0.017) and Peptoniphilus spp. (p =
0.039) (Figures 5A,B). This might suggest that there are specific
bacteria, commonly found in CST IV although occasionally in
other CSTs, that are responsible for high kynurenine/tryptophan
ratio levels, either due to elevated immune response or through
an active tryptophan metabolism.
Indole-Producing Bacteria Were Found in
94% of the Samples
Indole-producing bacterial species Porphyromonas
asaccharolytica, Propionibacterium acnes, Fusobacterium
nucleatum, Faecalibacterium prausnitzii, Enterococcus faecalis,
Peptoniphilus harei, and Escherichia coli, were found in 94% of
the samples analyzed, with maximum relative abundance among
individuals being 2.4% of reads. Higher relative abundance
of indole-producing bacteria were found among women
with CST IV (Figure 6A), and in women PAT (although not
statistically significant) (Figure 6B). These results verify that
indole-producing bacteria are commonly occurring within the
female vaginal microbiota, and that microbiota dysbiosis and
azithromycin treatment may be relevant to higher abundance of
these bacterial species.
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FIGURE 3 | Vaginal taxonomic distribution. (A) Heatmap of vaginal microbial taxa detected in women who were either C. trachomatis negative (chlamydial status:
CT-N in green), C. trachomatis positive single infection (CT-P in orange), samples were taken from women with current infection at second and third visit, post
antibiotic treatment (PAT in yellow) and C. trachomatis positive with repeated infection in the past year (CT-RP in red). Relative abundance of each taxa (species level
where possible) is presented by color, with red indicating higher abundance, and lighter shades of orange indicating lower abundance. To the right of the heatmap is
the nearest species as assigned by modified vaginal specific 16S database (Srinivasan et al., 2012), with the addition of several indole producing bacteria known to be
found in the human vaginal microbiome. For each of the women’s sample, CST, chlamydial status, pH, Nugent score, kynurenine/tryptophan ratios and vaginal IFN-γ
response data are presented. (B) Taxonomic distribution of CST I, III, and IV in our overall cohort. (C) Women’s chlamydial infection status distribution (CT-N, CT-P,
PAT, and CT-RP), among CST I, (D) CST III and (E) CST IV, presented as percentages.
DISCUSSION
Our study provides the first in vivo evidence that the IFN-γ-
Tryptophan-Indole-Microbiota axis is active during chlamydial
infections and the composition of the microbiota in the genital
tract may interplay considerably with the effectiveness of the host
response to chlamydial infection.
A well established, and in vitro validated hypothesis in the
field (Morrison, 2003), is that C. trachomatis infection triggers
a host IFN-γ response which leads to the upregulation of
IDO1, subsequently depleting tryptophan to kynurenine. Because
genital C. trachomatis is a tryptophan auxotroph, for it to survive
and cause reproductive infection, it must obtain tryptophan
somehow, potentially via indole from indole-producing bacteria
in the vaginal microbiota. We found that women with repeated
C. trachomatis infections had significantly elevated vaginal
kynurenine/tryptophan ratios. Despite the low number of
participants, our results suggest that indeed the chlamydial
infection did trigger an IFN-γ response and subsequent IDO1
production, which degraded pools of vaginal tryptophan to
kynurenine. Interestingly, when we measured vaginal IFN-γ
levels in these women, they actually had lower levels than in
controls. This might not be surprising, as high kynurenine,
along with low tryptophan levels were previously shown to alter
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FIGURE 4 | Vaginal tryptophan and kynurenine levels in women according to their CST. (A) Tryptophan (µg/ml), (B) kynurenine (ng/ml), and (C)
Kynurenine/tryptophan ratio, in women with CST I (n = 14), III (n = 17) and IV (n = 6). Women with CST IV had significantly lower levels of tryptophan in compare to
women with CST I (**p = 0.0058) and III (*p = 0.0126), using Mann-Whitney test. Data are presented as mean ± SD.
FIGURE 5 | Comparative analysis of kynurenine/tryptophan ratio measured from the women’s secretions samples with the mean relative abundance of OTUs
summarized to genus level. (A) Streptococcus spp. and (B) Peptoniphilus spp., higher abundance correlated with high kynurenine/tryptophan ratio. The
kynurenine/tryptophan ratio values are “low” < 3, “medium” 3 < 34 and “high” > 34. Statistical differences are indicated in the graph (**p < 0.05), using Kruskal Wallis
test.
FIGURE 6 | Relative abundance of indole-producing bacteria according to women’s CST and their Chlamydia infection status. (A) Abundance of indole producing
bacteria in women with CST I (n = 14), III (n = 17), and IV (n = 6). (B) Abundance of indole-producing bacteria in women who were Chlamydia negative (CT-N;
n = 10), Chlamydia positive (CT-P; n = 11), post antibiotic treatment (PAT; n = 13) and repeated Chlamydia infections (CT-RP; n = 3). No significant differences were
found. Data are presented as mean ± SD.
T-helper cells and down-regulate/alter the immune response
(including down regulation of IFN-γ) (Favre et al., 2010; Zelante
et al., 2014). For example, Chlamydia positive participant 214,
who had a high kynurenine/tryptophan ratio (235.6), with no
vaginal tryptophan detected, had only low levels of IFN-γ
(20.17 pg/ml). In addition, IL-17 levels were not detected
from this individual, which supports the suggestion that low
tryptophan and high kynurenine levels may suppress Th1
and Th17 immune response (Munn et al., 1999; Favre et al.,
2010).
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Dysbiosis of the vaginal microbiota is often characterized
by elevated pH levels, Nugent score (Ravel et al., 2011), fishy
odor (Nelson et al., 2015), discharge and diverse non-lactobacilli
bacterial communities (Srinivasan et al., 2012; Ravel et al., 2013),
which has been shown to alter the host immune response
(Mitchell and Marrazzo, 2014; Mackelprang et al., 2015) and
increase susceptibility to sexually transmitted infections and
other opportunistic pathogens (Martin et al., 1999; Wiesenfeld
et al., 2003). Consistent with this previous literature we found
that women with CST IV had higher pH levels, Nugent score
and higher presence of clue cells. Women with CST IV also
had significantly lower vaginal tryptophan levels, but not higher
kynurenine levels. This supports the proposal that the lower
tryptophan levels in the women who had a CST IV microbiota
was most likely due to tryptophan metabolism by the microbiota,
and not IDO1 induced immune response. Furthermore, we
also found that higher abundance of Streptococcus spp. and
Peptoniphilus spp. (previously described to be associated with
BV), was correlated with higher vaginal kynurenine/tryptophan
ratio levels. This might indicate that vaginal kynurenine and
tryptophan are not influenced solely by direct host IFN-
γ-mediated immune response, but also via the presence of
certain bacteria colonizing the genital tract, again, either due to
modification of the immune response or by active tryptophan
metabolism. Of the three Peptoniphilus spp. detected in the
vaginal microbiota of women in our cohort, two of them, P.
duerdenii and P. harei are tryptophan auxotrophs (Uniprot.org)
and therefore, are predicted to exploit the host tryptophan pools,
which may lead to low tryptophan levels. In addition, P. harei,
which was found to have relatively high abundance (indicated
in Figure 3), is an indole-producer, which may further deplete
the host tryptophan pools. This suggests that the presence of
Peptoniphilus spp. may be related to high kynurenine/tryptophan
ratios due to active tryptophan metabolism by bacteria from
this genus. Although from all seven different Streptococcus spp.
detected in the vaginal microbiota of women in our study, only
Streptococcus agalactiae is a tryptophan auxotroph (Uniprot.org),
there is evidence that toxins being produced by Streptococcus
spp. may influence tryptophan degradation via IDO1 through the
induction of IFN-γ (Man and Werner-felmayer, 1997).
The vaginal microbiota of a particular CST may affect
measurements of kynurenine and tryptophan, as well as the
cytokine response. However, because of the complex interactions
between the microbial communities in the vaginal tract, host
genotype and their immune response, a direct association
between CST and IFN-γ levels or kynurenine/tryptophan ratios
in specific individuals is difficult to determine and variations
may often occur. For example, some women with microbiota
of CST I had high kynurenine/tryptophan ratios or high IFN-
γ levels. This could be explained by other measurements taken
from the same individuals, such as their Chlamydia status or
the relative abundance of certain bacterial species that may
have contributed to these changes. Women with CST I and
high vaginal IFN-γ levels, such as 108, 202, 204, and 210,
all had low kynurenine/tryptophan ratios, however, they were
always accompanied by high IL-17. Participants 210 and 204
had a previous Chlamydia infection and participant 202 had
a current Chlamydia infection. Participant 108 with CST I,
was Chlamydia negative, however, they had a high relative
abundance of indole-producing bacteria (0.23%), and specifically
Propionibacterium acnes. Participant 106, with CST III and
high IFN-γ levels also showed a high relative abundance of
Prevotella spp. (0.25%). Participant 212, who had CST IV, had
no tryptophan or kynurenine in their vaginal secretion sample.
This could be due to a low amount of secretions available from
this specific individual, which might result in levels that are
below the detection of the tryptophan and kynurenine ELISA
(tryptophan< 1.2µg/ml, kynurenine< 47.5 ng/ml). In addition,
the participant had presented with Chlamydia infection in the
previous visit, with CST III and a pH of 5, which supports
the observation that vaginal dysbiosis may be associated with
Chlamydia infection.
Whilst not significant, women with CST IV had higher rates
of previous or current chlamydial infection (84%), as well as
higher abundance of indole-producing bacteria. The prevalence
of indole-producing bacteria within out study cohort was 94%,
with the maximum relative abundance of 2.4% of individual’s
total reads. This suggests that perhaps CST IV provides the
most suitable environment for indole production, due to higher
pH levels and divers microbial community with low lactic acid
production. In addition, the low vaginal tryptophan levels in
women with CST IV could be due to tryptophan catabolism
into indole by indole-producing bacterial species that contain
the tnaA gene. This could support the hypothesis that indole-
producing bacteria are indeed a contributing factor, to assist
chlamydial survival under conditions of immune response-
induced tryptophan depletion. This is the first study to analyze
the presence of indole producing bacteria in women’s vaginal
microbiota and their role during Chlamydia infections. Previous
studies have identified several indole- producing bacteria (Albert
et al., 2015), however, we added several more species to our
database such as Propionibacterium acnes, which were then
identified within our cohort.
In this case, the host immune response strategy of killing
the Chlamydia by starving it from tryptophan might not be as
beneficial, (a) Firstly, because C. trachomatis genital strains have
retained their tryptophan synthase gene and indole-producing
bacteria are indeed more prevalent under conditions of vaginal
CST IV and (b) secondly, depletion of tryptophan in this
environment might compromise host immune defense against
opportunistic pathogens and indicate decreased numbers of
lactic acid-producing bacterial communities.
In this study, CST IV was found to be associated with the
lowest levels of vaginal tryptophan levels, as well as higher
abundance of indole-producing bacteria, that can also contribute
to (a) elevated pH levels, (b) tryptophan depletion, and (c) supply
of exogenous indole that can be used by the Chlamydia to
survive tryptophan starvation. The most significant risk factor
for C. trachomatis infection is probably exposure. However, the
host microbiome CST present at the time of the exposure might
contribute significantly to the effectiveness and type of each
individual’s immune response to resolve the infection, or not.
These factors might also contribute to the level of the Chlamydia
infection, reproductive outcomes and disorders, and a possibility
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to a higher susceptibility to opportunistic pathogen colonization
during or after chlamydial infections. Perhaps the combination
of an active chlamydial infection, along with microbiota of CST
IV and especially the presence of certain bacterial species, such
as Streptococcus and Peptoniphilus, might contribute to vaginal
dysbiosis and repeated chlamydial infections in the case of
repeated exposure.
In the era of “omics” approaches and individualized medicine,
our results demonstrate that measuring patient factors, such
as vaginal microbiome composition, and metabolic levels (such
as tryptophan and kynurenine), in addition to usual diagnosis
of sexual contact and STIs, can directly contribute to an
individual’s sexual health. Other recent research in gut, oral
and reproductive-tract sites has shown the importance of the
microbiota composition and dysbiosis state on disease processes
and on health overall. Our findings suggest that in the case
of C. trachomatis infections, tryptophan and kynurenine levels,
measured directly in vaginal secretions might provide a relatively
simple marker for microbiota dysbiosis and even subsequent
adverse results from chlamydial infections.
In summary, despite the low number of participants, our pilot
study provides preliminary results in which we were able to show
for the first time in vivo, that high vaginal kynurenine/tryptophan
ratio levels correlate with repeated C. trachomatis infections
and most likely this is due to the immune response inducing
IDO1 activity. Tryptophan was significantly lower in women
whose microbiota was consistent with CST IV, and there was
also a higher relative abundance of indole producers in this
type of vaginal microbiota composition, which could explain
the low tryptophan levels. High abundance of indole-producing
bacteria was found in women PAT, and might indicate a
destructive effect of antibiotic treatment on vaginal health
after chlamydial infection. Our results shed further light on
tryptophan depletion mechanisms during chlamydial infection
and indicate the important role of the vaginal microbiota.
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